# Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.

> **NCT01177566** · PHASE4 · COMPLETED · sponsor: **Emer, Jason, M.D.** · enrollment: 20 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** pimecrolimus
- **DEVICE:** topical medical device

## Key facts

- **NCT ID:** NCT01177566
- **Lead sponsor:** Emer, Jason, M.D.
- **Sponsor class:** INDIV
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-09
- **Primary completion:** 2010-03
- **Final completion:** 2010-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2010-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01177566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01177566, "Pimecrolimus Cream 1% (Elidel®) and Medicated Device Cream (EletoneTM) in the Treatment and Maintenance of Atopic Dermatitis.". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT01177566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*